Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Size And Growth In 2026: Key Factors Shaping Future Demand
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Forecast: What Value Will The Market Reach By 2030?
The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market size has seen rapid growth recently. It is forecast to increase from $0.68 billion in 2025 to $0.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. This historical expansion can be attributed to the rising occurrence of sexually transmitted infections, the drawbacks of older diagnostic approaches, greater understanding of women’s reproductive health, the growth in clinical diagnostic laboratories, and the implementation of standard pcr testing methods.
The sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market size is anticipated to expand significantly over the next few years, reaching $1.08 billion in 2030, driven by a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period can be ascribed to an increasing need for point-of-care molecular diagnostics, advancements in multiplex and real-time PCR technology, wider acceptance of home-based testing solutions, heightened investments in molecular diagnostic infrastructure, and the expansion of screening programs for STI and vaginitis. Notable trends expected in this period include the rising adoption of multiplex PCR panels for STI and vaginitis detection, a growing preference for rapid and highly sensitive molecular diagnostics, increased demand for at-home and self-collected PCR testing kits, the broader integration of PCR testing into routine women’s health screening, and an intensified focus on early and precise pathogen identification.
Get A Free Sample Report With In-Depth Market Insights:
Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Growth Drivers: What’s Behind The Acceleration?
A rise in sexual health screenings is projected to fuel the expansion of the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in the future. Sexual health screenings are defined as medical examinations performed to identify sexually transmitted infections (STIs) and associated conditions, facilitating prompt diagnosis, therapy, and control of disease dissemination. The global increase in the prevalence of sexually transmitted infections is leading to more sexual health screenings, driven by a greater demand for early identification and prompt intervention to avert complications and limit disease transmission. These screenings are vital for STI and vaginitis PCR testing as they enable accurate and early detection of numerous infections, frequently before symptoms appear, thereby aiding rapid treatment and helping prevent subsequent complications and further infection spread. As an illustration, the Bristol City Council, a UK government body, reported in July 2025 that during 2024, sexual health services carried out 25,410 STI tests (excluding chlamydia screening for individuals under 25). This figure represents 5,260.9 tests per 100,000 population, surpassing the England average of 4,088.8 per 100,000. Consequently, the expansion of sexual health screenings is propelling the growth of the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market.
Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Segment Analysis: What Are The Core Market Categories?
The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market covered in this report is segmented –
1) By Test Type: Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, Vaginitis Polymerase Chain Reaction (PCR) Panels
2) By Condition: Sexually Transmitted Infections, Vaginal Infections
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Or At-Home Testing, Other End Users
Subsegments:
1) By Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels: Chlamydia Trachomatis Polymerase Chain Reaction, Neisseria Gonorrhoeae Polymerase Chain Reaction, Trichomonas Vaginalis Polymerase Chain Reaction, Herpes Simplex Virus Polymerase Chain Reaction, Human Papillomavirus Polymerase Chain Reaction, Mycoplasma Genitalium Polymerase Chain Reaction, Syphilis Polymerase Chain Reaction, Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
2) By Vaginitis Polymerase Chain Reaction (PCR) Panels: Bacterial Vaginosis Polymerase Chain Reaction, Candida Species Polymerase Chain Reaction, Trichomoniasis Polymerase Chain Reaction, Mixed Vaginitis Polymerase Chain Reaction Panels, Aerobic Vaginitis Polymerase Chain Reaction, Atrophic Vaginitis Polymerase Chain Reaction
Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Trends: What’s Defining The Industry’s Next Phase?
Leading firms within the sexually transmitted infection (STI) and vaginitis PCR testing market are developing advanced technologies, including multiplex real-time PCR assays, to meet the increasing demand for swift, precise, and thorough pathogen identification. This multiplex PCR approach allows for the concurrent amplification and identification of DNA or RNA from various pathogens using a single test, thereby cutting down both processing time and expenses when contrasted with conventional single-pathogen tests. Furthermore, this method enhances sensitivity and specificity, making it possible to detect minute quantities of pathogen genetic material, even in concurrent infections, which traditional culture or microscopy techniques might overlook or identify with less certainty. An illustrative example occurred in February 2023, when Thermo Fisher Scientific, a US-based biotechnology firm, introduced the Applied Biosystems TrueMark STI Select Panel. This product is a multiplex real-time PCR assay specifically engineered to concurrently identify four prevalent STIs: Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. Although intended for research purposes, this diagnostic test improves clinical results by offering quicker, highly sensitive detection and optimizing laboratory processes, marking a considerable step forward in molecular STI diagnostics.
Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Competitive Overview And Top Companies
Major companies operating in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd., Sinochips Diagnostics Co Ltd., Vitassay S.L., Bioperfectus Technologies Co. Ltd.
View The Full Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Report:
Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in 2025. The regions covered in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
